ETFs That Hold Monte Rosa Therapeutics (GLUE)
Like Monte Rosa Therapeutics but not the single-stock risk? Find every fund that holds it, ranked by how much. Flip the lens to find the cleanest way to own it, the most diversified wrapper, or (in avoidance mode) which of your funds sneak it in.
Reverse lookup across 225 global listings · ranked by portfolio weight. Weights are the latest holdings each fund reported, refreshed in the background, so the weights and the holder, issuer and listing counts this page prints can all shift between two loads. Fee and assets are joined for every holder from the nightly fund profile, not read live. Exposure data is decision-support, not a recommendation · Not investment advice.
Common questions
How many ETFs hold Monte Rosa Therapeutics (GLUE)?
Monte Rosa Therapeutics (GLUE) is held by 66 US-listed ETFs, in each fund's latest reported holdings.
Which ETF holds the most Monte Rosa Therapeutics?
Of the US-listed ETFs in our fund data, T. Rowe Price Biotech ETF (TDNA) holds Monte Rosa Therapeutics at the largest portfolio weight, in each fund's latest reported holdings.
What ETFs hold Monte Rosa Therapeutics?
By portfolio weight, the US-listed ETFs that hold the most Monte Rosa Therapeutics are TDNA, BBC, BUSM, XBI and IWC, among others, in each fund's latest reported holdings.